Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)

B. C. M. Hermans, J. L. Derks, E. Thunnissen, R. J. van Suylen, M. A. den Bakker, H. J. M. Groen, E. F. Smit, R. A. Damhuis, E. C. van den Broek, C. M. Stallinga, G. M. Roemen, E. J. M. Speel, A. -M. C. Dingemans*, PALGA Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Web of Science)
Original languageEnglish
Pages (from-to)179-186
Number of pages8
JournalLung Cancer
Volume130
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Large cell neuroendocrine carcinoma
  • Lung cancer
  • PD-L1
  • CD8
  • Prognosis
  • LUNG-CANCER
  • CHEMOTHERAPY
  • BLOCKADE

Cite this